Skip to main content
. 2016 May 27;7(28):43052–43061. doi: 10.18632/oncotarget.9678

Table 1. Clinical features of dural MZL patients.

Case No. Age Sex Symptoms Site Imaging Therapy Outcome Follow up duration (months)
1 62 F Headaches, right sided discoordination Cranial Dura Solitary mass RTX, CTX Dead- Unrelated cause 29
2 48 F Left jaw numbness, left-sided auditory defects Cranial Dura Solitary mass Surgery Alive- NED 77
3 33 F Headaches, left sided weakness, seizures Cranial Dura Solitary mass RTX Alive- NED 26
4 57 F Headache Cranial Dura/Parotid Solitary mass Surgery, CTX Alive-NED 20
5 45 F Back pain and spasms Spinal Dura Solitary mass N/A Alive- NED 120
6 42 F Headaches Cranial Dura Solitary mass RTX Alive- NED 29
7 60 F N/A Cranial Dura Solitary mass RTX Alive- NED 22
8 34 F Seizures Cranial Dura Solitary mass CTX Alive- NED 12
9 62 F Headaches, right-sided numbness Cranial Dura Solitary mass CTX Alive-NED N/A
10 50 F N/A Cranial Dura Solitary mass N/A N/A N/A
11 53 M N/A Cranial Dura Solitary mass Surgery Alive-NED 204
12 43 F Headache, syncope and neurologic deficits Cranial Dura Solitary mass RTX Alive-NED 108
13 42 F Seizures Cranial Dura Solitary mass N/A N/A N/A
14 37 M N/A Cranial Dura Solitary mass N/A N/A N/A

F: female; M: male; N/A: not available; RTX: radiation therapy; CTX: chemotherapy; NED: no evidence of disease